These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25735345)

  • 21. Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
    Ogama Y; Ouchida M; Yoshino T; Ito S; Takimoto H; Shiote Y; Ishimaru F; Harada M; Tanimoto M; Shimizu K
    Int J Oncol; 2004 Sep; 25(3):685-91. PubMed ID: 15289870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells].
    Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    Lin YL; Sun G; Liu XQ; Li WP; Ma JG
    J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The H-cadherin (CDH13) gene is inactivated in human lung cancer.
    Sato M; Mori Y; Sakurada A; Fujimura S; Horii A
    Hum Genet; 1998 Jul; 103(1):96-101. PubMed ID: 9737784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.
    Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
    DNA Cell Biol; 2014 Apr; 33(4):205-16. PubMed ID: 24491043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs.
    Putku M; Kals M; Inno R; Kasela S; Org E; Kožich V; Milani L; Laan M
    Hum Genet; 2015 Mar; 134(3):291-303. PubMed ID: 25543204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
    Jin Z; Cheng Y; Olaru A; Kan T; Yang J; Paun B; Ito T; Hamilton JP; David S; Agarwal R; Selaru FM; Sato F; Abraham JM; Beer DG; Mori Y; Shimada Y; Meltzer SJ
    Int J Cancer; 2008 Nov; 123(10):2331-6. PubMed ID: 18729198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
    Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis.
    Chen C; Hua H; Han C; Cheng Y; Cheng Y; Wang Z; Bao J
    Int J Clin Exp Pathol; 2015; 8(9):11560-4. PubMed ID: 26617891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer.
    Sakai M; Hibi K; Koshikawa K; Inoue S; Takeda S; Kaneko T; Nakao A
    Cancer Sci; 2004 Jul; 95(7):588-91. PubMed ID: 15245595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of
    Pu W; Geng X; Chen S; Tan L; Tan Y; Wang A; Lu Z; Guo S; Chen X; Wang J
    J Cancer; 2016; 7(15):2280-2289. PubMed ID: 27994665
    [No Abstract]   [Full Text] [Related]  

  • 36. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
    Chang Z; Zhou H; Liu Y
    Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RASSF1A gene methylation is associated with nasopharyngeal carcinoma risk in Chinese.
    Wu K; Xu XN; Chen Y; Pu XL; Wang BY; Tang XD
    Asian Pac J Cancer Prev; 2015; 16(6):2283-7. PubMed ID: 25824751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.
    Li Y; Zhu M; Zhang X; Cheng D; Ma X
    Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation markers and early recurrence in stage I lung cancer.
    Brock MV; Hooker CM; Ota-Machida E; Han Y; Guo M; Ames S; Glöckner S; Piantadosi S; Gabrielson E; Pridham G; Pelosky K; Belinsky SA; Yang SC; Baylin SB; Herman JG
    N Engl J Med; 2008 Mar; 358(11):1118-28. PubMed ID: 18337602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
    Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.